Auro Laboratories Ltd.

View in App
135.70 ▼0%

28 November 2023, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aurolabs.com
Market Cap 84.58 Cr.
Enterprise Value(EV) 92.94 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 7.74 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 17.52 Trailing Twelve Months Ending 2023-09
Industry PE 37.97 Trailing Twelve Months Ending 2023-09
Book Value / Share 59.38 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.29 Calculated using Price: 135.70
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.62 Cr. 6,232,500 Shares
FaceValue 10
About Auro Laboratories Ltd.
Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. The company is promoted by Shri Sharat Deorah and Shri Satish Deorah.

Auro Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Auro Laboratories Ltd. Performance

View details >>
1 Day
1 Week
-7.69%
1 Month
+21.43%
3 Month
+3.24%
6 Month
+63.49%
1 Year
+82.15%
2 Year
+32.65%
5 Year
+119.58%
10 Year
+2268.24%

Auro Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 11.01 10.83 9.06 31.53 28.95 20.84 28.67 9.47 7.43
Return on Capital Employed (%) 10.76 11.21 20.24 28.65 29.12 24.80 38.88 12.20 9.92
Return on Assets (%) 2.89 3.24 3.11 12.34 13.78 12.32 19.34 5.87 4.40

Auro Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 8 9 9 13 17 22 29 32 34 37
Non Curr. Liab. 8 7 11 8 6 5 4 3 4 11
Curr. Liab. 14 10 6 10 10 6 9 20 18 14
Minority Int.
Equity & Liab. 29 26 27 30 33 32 42 55 56 62
Non Curr. Assets 11 13 13 15 15 14 14 18 21 26
Curr. Assets 18 12 14 16 19 18 28 37 35 36
Misc. Exp. not W/O
Total Assets 29 26 27 30 33 32 42 55 56 62

Auro Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 33 28 35 41 47 44 54 51 53 53
Other Income 0 0 1 1 1 1 1 1 1 2
Total Income 33 28 36 41 48 45 55 52 54 54
Total Expenditure -30 -25 -31 -34 -40 -38 -43 -46 -49 -46
PBIDT 3 3 5 7 8 7 12 6 5 9
Interest -2 -2 -1 -1 -1 -1 0 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -2 -1 -2 -2 -3 -1 -1 -2
Exceptional Items
PAT 1 1 1 4 4 4 7 3 2 5
Adjusted EPS 1 1 1 6 7 7 12 5 4 8

Auro Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 -1 8 6 5 7 9 13 -7 3
Cash Fr. Inv. -1 -1 -2 -2 -2 -3 -2 -4 -5 -5
Cash Fr. Finan. -3 1 -5 -4 -2 -2 -6 0 10 -8
Net Change 1 -1 0 0 1 2 2 9 -2 -10
Cash & Cash Eqvt 1 0 1 1 2 4 6 15 12 2

Auro Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 51.93 51.99 51.99 52.09 52.09 52.09 52.09 52.09 41.03
Public 48.07 48.01 48.01 47.91 47.91 47.91 47.91 47.91 58.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Auro Laboratories Ltd. Announcements

View details >>
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Thu, 09 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Dated November 9 2023
We wish to inform that the Board of directors of our Company in their meeting held today i.e November 9 2023 has considered and approved the unaudited financial results for the quarter and half year ended September 30 2023.
Thu, 09 Nov 2023
Results For Quarter And Half Year Ended September 30 2023
Results

Auro Laboratories Ltd. Technical Scans

View details >>
Tue, 28 Nov 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days

Auro Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 285,856.77 1,196.40 +0.4%
Divi's Laboratories Ltd. 99,768.40 3,753.00 -0.2%
Cipla Ltd. 96,240.20 1,197.45 +0.4%
Dr. Reddy's Laboratories Ltd. 94,596.57 5,682.45 +0.1%
Apollo Hospitals Enterprise Ltd. 77,163.47 5,407.95 +0.8%
Mankind Pharma Ltd. 75,957.58 1,929.95 +1.8%
Torrent Pharmaceuticals Ltd. 70,389.88 2,101.45 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.44 1,196.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 74.91 3,753.00 -0.2%
Cipla Ltd. Consolidated 2023-09 27.87 1,197.45 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.58 5,682.45 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 110.63 5,407.95 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 59.26 1,929.95 +1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.77 2,101.45 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.78 1,196.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.87 3,753.00 -0.2%
Cipla Ltd. Consolidated 2023-09 3.88 1,197.45 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.71 5,682.45 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.87 5,407.95 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 9.01 1,929.95 +1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,101.45 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,196.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,753.00 -0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,197.45 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,682.45 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,407.95 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,929.95 +1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,101.45 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,196.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,753.00 -0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,197.45 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,682.45 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,407.95 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,929.95 +1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,101.45 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,196.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,753.00 -0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,197.45 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,682.45 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,407.95 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,929.95 +1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,101.45 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,196.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,753.00 -0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,197.45 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,682.45 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,407.95 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,929.95 +1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,101.45 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,196.40 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,753.00 -0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,197.45 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,682.45 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,407.95 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,929.95 +1.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,101.45 +1.1%

Auro Laboratories Ltd. FAQ's

What is Auro Laboratories share price?
Can I buy Auro Laboratories shares now?
What is the Market Cap of Auro Laboratories?
What are the key metrics to analyse Auro Laboratories?
What is the 52 Week High and Low of Auro Laboratories?